Hikma Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Amman Jordan (1978)
Status: No NME R&D (1978)

Organization Overview

First Clinical Trial
2001
NCT00168922
First Marketed Drug
1978
methadone (methadose)
First NDA Approval
1980
trilithium citrate
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

HIKMA | HIKMA FARMACEUTICA | HIKMA INTL PHARMS | Hikma Pharma | Hikma Pharmaceuticals LLC | Hikma Pharmaceuticals USA Inc. | HIKMA PHARMACEUTICALS USA INC | Hikma Pharma,Egypt | HIKMA PHARM CO LTD | HIKMA PHARMS | ribosepharm GmbH